MedTrace Logo

Medical Office Intervention for Adolescent Drug Use - Attention Study Supplement

NCT00593034 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2011-03-08

No results posted yet for this study

Summary

This study will use the CCPT II to assess attention in 12-21 year olds enrolled in a randomized controlled trial of a brief behavioral treatment for substance abuse.

This study will describe at baseline levels of attention using a well validated instrument (Connors Continuous Performance Test II) and explore the association between attention levels and substance use. The primary study hypothesis is that lower initial levels of substance use (as measured by percent days abstinent) will be associated with higher attention levels. We envision that this data will inform a better understanding of how attention may modify treatment response.

Conditions

  • Substance-related Disorders

Sponsors & Collaborators

Principal Investigators

  • John R Knight, MD · Boston Children's Hospital

Eligibility

Min Age
12 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2008-02-29
Completion
2008-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00593034 on ClinicalTrials.gov